119 related articles for article (PubMed ID: 32561913)
1. COVID-19 and the Renin-Angiotensin-Aldosterone System.
Naik GOA
Clin Infect Dis; 2021 Mar; 72(6):1105-1107. PubMed ID: 32561913
[No Abstract] [Full Text] [Related]
2. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
[No Abstract] [Full Text] [Related]
3. Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?
Henry RA
CMAJ; 2020 Jun; 192(26):E728. PubMed ID: 32601254
[No Abstract] [Full Text] [Related]
4. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.
Usman MS; Siddiqi TJ; Khan MS; Ahmed A; Ali SS; Michos ED; Hall ME; Krasuski RA; Greene SJ; Butler J; Alkhouli M
Am J Cardiol; 2020 Sep; 130():159-161. PubMed ID: 32624189
[No Abstract] [Full Text] [Related]
5. Renin-angiotensin system blockers and COVID-19.
Vidal-Petiot E; Gault N
BMC Med; 2021 Jun; 19(1):136. PubMed ID: 34082752
[No Abstract] [Full Text] [Related]
6. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
7. Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
Mackey K; Kansagara D; Vela K
Ann Intern Med; 2021 Jan; 174(1):W17. PubMed ID: 33253036
[No Abstract] [Full Text] [Related]
8. Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients.
Sriram K; Insel PA
Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L37-L38. PubMed ID: 33496632
[No Abstract] [Full Text] [Related]
9. SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications.
Ye Q; Lai EY; Luft FC; Persson PB; Mao J
Acta Physiol (Oxf); 2021 Apr; 231(4):e13608. PubMed ID: 33350096
[No Abstract] [Full Text] [Related]
10. [Cardiac Involvement in COVID-19].
Sugraliyev AB
Kardiologiia; 2021 May; 61(4):15-23. PubMed ID: 33998404
[TBL] [Abstract][Full Text] [Related]
11. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
Zhou F; Liu YM; Xie J; Li H; Lei F; Yang H; Qin JJ; Cai J; Zhang XJ; Wu B; Xia M; Xiang D; Yang C; Ma X; Xu Q; Lu Z; Lu H; Xia X; Wang D; Liao X; Peng G; Yang J; Huang X; Zhang BH; Yuan Y; Wei X; Liu PP; Wang Y; Zhang P; She ZG; Xia J; Li H
Hypertension; 2020 Aug; 76(2):e15-e17. PubMed ID: 32493070
[No Abstract] [Full Text] [Related]
12. Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity.
Otto CM
Heart; 2020 Oct; 106(19):1451-1453. PubMed ID: 32928982
[No Abstract] [Full Text] [Related]
13. Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)?
Kow CS; Hasan SS
Clin Infect Dis; 2021 Jul; 73(1):164-165. PubMed ID: 32770237
[No Abstract] [Full Text] [Related]
14. Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic.
Kow CS; Hasan SS
Expert Rev Cardiovasc Ther; 2021 Jan; 19(1):99-100. PubMed ID: 33112190
[No Abstract] [Full Text] [Related]
15. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
Buckley LF; Cheng JWM; Desai A
J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
[TBL] [Abstract][Full Text] [Related]
16. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients.
Baral R; White M; Vassiliou VS
Curr Atheroscler Rep; 2020 Aug; 22(10):61. PubMed ID: 32830286
[TBL] [Abstract][Full Text] [Related]
17. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
Brojakowska A; Narula J; Shimony R; Bander J
J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients.
Jung C; Bruno RR; Wernly B; Joannidis M; Oeyen S; Zafeiridis T; Marsh B; Andersen FH; Moreno R; Fernandes AM; Artigas A; Pinto BB; Schefold J; Wolff G; Kelm M; De Lange DW; Guidet B; Flaatten H; Fjølner J;
Eur Heart J Cardiovasc Pharmacother; 2021 Jan; 7(1):76-77. PubMed ID: 32645153
[No Abstract] [Full Text] [Related]
19. COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?
Tadic M; Cuspidi C
J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1984-1986. PubMed ID: 32951351
[No Abstract] [Full Text] [Related]
20. The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity.
Liao WH; Yang GG; Henneberg M
Swiss Med Wkly; 2020 Nov; 150():w20444. PubMed ID: 33306813
[No Abstract] [Full Text] [Related]
[Next] [New Search]